We are proud to join forces with a new coalition of leading organizations including @theaacr.bsky.social, @break-cancer.bsky.social, @lustgarten.org & @themarkfdn.bsky.social! Together we will fund $12mm to 6 teams focused on early detection of some of the most challenging cancers including ovarian.
04.02.2026 16:47 — 👍 4 🔁 1 💬 0 📌 0
@landau.bsky.social @rdrapkin8-penn.bsky.social Paul Mischel, and Adam Widman are searching for pre-cancerous signals of ovarian cancer in the blood, laying the foundation for non-invasive screening test. 🩸@tinaswish.bsky.social
@weillcornell.bsky.social @mskcancercenter.bsky.social
03.02.2026 18:16 — 👍 5 🔁 2 💬 1 📌 0
Peter Sorger, David Walt, Sandro Santagata, and @rdrapkin8-penn.bsky.social are mapping ovarian cancer precursors to enable detection and treatment of the disease while it is still localized. 🗺️💊 @break-cancer.bsky.social
@harvard.edu @pennmedicine.bsky.social
03.02.2026 18:16 — 👍 0 🔁 0 💬 1 📌 0
Christina Curtis, Greg Charville, William Grady, and Rebecca Fitzgerald are using AI & advanced computational tools to spot early warning signs in the esophagus before cancer develops. 🖥️🔍 @break-cancer.bsky.social
@stanford-cancer.bsky.social
03.02.2026 18:16 — 👍 0 🔁 0 💬 1 📌 0
Trevor Pugh, Brian Crompton, @doctorpauln77.bsky.social, and @karanoelle.bsky.social are developing an accurate, accessible blood test for patients with very high inherited cancer risk due to conditions such as Li-Fraumeni Syndrome. 🧬
@stjuderesearch.bsky.social
@danafarber.bsky.social
03.02.2026 18:16 — 👍 1 🔁 0 💬 1 📌 0
Brian Wolpin, Andrew Aguirre, Julie Sutcliffe, and Laura Wood are using new drugs to detect and "label" pre-cancerous lesions in the pancreas and prevent their progression to advanced cancer. 🛑
@danafarber.bsky.social
@ucdavis.bsky.social
03.02.2026 18:16 — 👍 0 🔁 0 💬 1 📌 0
Nikolaos Sgourakis, Mark Sellmyer, & @possuhuanglab.bsky.social are developing radioactive imaging agents to detect KRAS mutations, which drive 90% of pancreatic tumors but can’t currently be seen on scans. ☢️
@stanford.edu
@upenn.edu
03.02.2026 18:16 — 👍 0 🔁 0 💬 1 📌 0
Where is the Money for Cancer Research Going to Come From Now?
Institutes and private organizations like the Mark Foundation are promising to spend more on cancer research to counteract a decline in federal dollars.
In an increasingly uncertain funding environment, how can philanthropy effectively support cancer research? In After Treatment, CEO Ryan Schoenfeld tells
@grogowl.bsky.social how The Mark Foundation continues to advance game-changing science.
www.after-treatment.com/p/where-is-t...
27.01.2026 14:54 — 👍 1 🔁 0 💬 0 📌 0
Researchers discover new treatments to prevent growth of two cancers
The research looked at the genes which can cause cancer, with a focus on the bowel and liver
🚨 New research from the CancerGrand Challenges SPECIFICANCER team (co-funded by The Mark Foundation & @cancerresearchuk.org) highlights NPM1 as a promising target for bowel & liver cancer.
Read more in @the-independent.com:
www.independent.co.uk/news/health/...
21.01.2026 19:20 — 👍 0 🔁 0 💬 0 📌 0
Congratulations to Mark Foundation Scientific Advisory Committee chair and Board member @rosslevinemd.bsky.social !
15.01.2026 16:13 — 👍 2 🔁 0 💬 0 📌 0
Since 2018, the ELA program has awarded over $40M to spark innovation. This year, we are also proud to partner with The Bakewell Foundation to support Jeremy Borniger’s unconventional and bold research. 🤝
14.01.2026 11:15 — 👍 0 🔁 0 💬 0 📌 0
Christopher Johnston is engineering human-derived bacteria to act as "cellular therapies," infiltrating solid tumors to deliver medicine directly into the most treatment-resistant environments. 🧫 @mdanderson.bsky.social
14.01.2026 11:15 — 👍 0 🔁 0 💬 1 📌 0
Mariella Filbin is exploring how aggressive childhood brain tumors hijack normal brain activity to repair their own DNA. This research aims to break through radiation resistance in diffuse midline gliomas. 🧠 @danafarbernews.bsky.social
14.01.2026 11:15 — 👍 0 🔁 0 💬 1 📌 0
Lucas Farnung will use "visual biochemistry" at atomic resolution to see exactly how errors in DNA replication drive cancer. This high-def view will reveal brand-new targets for drug development. 🔬 @harvardmed.bsky.social @lucas.farnunglab.com
14.01.2026 11:15 — 👍 10 🔁 2 💬 1 📌 0
Iok In Christine Chio is developing non-invasive imaging to detect pancreatic cancer in its earliest stages by tracking how the disease redistributes iron throughout the body. 🔍 @columbiacancer.bsky.social @columbiamed.bsky.social
14.01.2026 11:15 — 👍 0 🔁 0 💬 1 📌 0
Jeremy Borniger, The Bakewell Foundation Emerging Leader Awardee, will investigate "synthetic torpor"—inducing a hibernation-like state to globally suppress metabolism. The goal? Starve tumors while sparing healthy tissue. ❄️🧬 @cshlnews.bsky.social
14.01.2026 11:15 — 👍 0 🔁 1 💬 1 📌 0
📢 Announcing The Mark Foundation 2026 Emerging Leader Award winners! 📢
We are committing $3.75 million to 5 visionary early-career scientists poised to lead the next generation of oncology breakthroughs. We can't wait to see their impact!
themarkfoundation.org/2026/01/2026...
14.01.2026 11:15 — 👍 10 🔁 3 💬 2 📌 0
We're back from the @theaacr.bsky.social Special Conference on Early Onset Cancers! A major highlight was the update from Mark Foundation-Waxman Foundation grantee Ashani Weeraratna on her research into how the aging tumor immune microenvironment influences tumor progression. #AACRearlyonset25
15.12.2025 21:23 — 👍 1 🔁 1 💬 1 📌 0
📢 New Impact Report from SPECIFICANCER, the team unravelling one of cancer biology’s hardest puzzles: tissue specificity.
A huge thank you to the team and thanks to our co-funders, @themarkfdn.bsky.social and @cancerresearchuk.org for supporting global science.
🔗 lnkd.in/dQC-iHmK
08.12.2025 15:38 — 👍 3 🔁 1 💬 0 📌 0
The breakthrough builds on work Paul Thomas conducted through a ASPIRE Award granted in partnership with the Fibrolamellar Cancer Foundation. It offers new hope for FLC patients — and a new path forward for therapeutic vaccines targeting so-called “undruggable” cancer drivers.
04.12.2025 21:07 — 👍 0 🔁 0 💬 0 📌 0
From bench to bedside! In a Phase 1 trial, a vaccine targeting a neoantigen in fibrolamellar hepatocellular carcinoma (FLC), a rare liver cancer primarily affecting younger people, showed significant clinical benefit when combined with immune checkpoint inhibitors. www.nature.com/articles/s41...
04.12.2025 21:07 — 👍 0 🔁 0 💬 1 📌 0
Every day counts in the fight against cancer—and we can’t afford to let reduced federal funding slow progress. Your support this #GivingTuesday helps The Mark Foundation fund ambitious science and bring breakthroughs to the patients who need them. themarkfoundation.org/donate/
02.12.2025 15:00 — 👍 0 🔁 0 💬 0 📌 0
Read the newly published impact report from the SPECIFICANCER team that reshaped our understanding of tissue specificity.
Thanks to our co-funders, @themarkfdn.bsky.social, for supporting the #CancerGrandChallenges team and global science.
🔗 lnkd.in/eDrQ9guu
01.12.2025 16:48 — 👍 5 🔁 3 💬 0 📌 0
St. Jude Children's Research Hospital: a leader in research and treatment of pediatric cancer and childhood diseases.
Highlighting Stanford Medicine's world-class cancer research, prevention, and treatment. The Stanford Cancer Institute is dedicated to transforming cancer care. https://med.stanford.edu/cancer.html
Professor at the University of Pennsylvania. Director of UPenn Ovarian Cancer Research Center.
Our lab focuses on the factors that drive ovarian tumorigenesis - it's totally tubular!
Know early. Know hope.® Dedicated to funding research for the early detection and prevention of ovarian cancer. Tinaswish.org
Physician Scientist at MSK. All views expressed here are my own & do not represent my employer. COI:http://bit.ly/2LQCLKe
Non-profit research and educational institution at the forefront of molecular biology, cancer, neuroscience, plant biology, and genetics.
https://www.cshl.edu/
We work on minimal residual disease and metastasis by colorectal cancer from the perspective of cancer stem cells and their interaction with the tumor microenvironment.
@IRBBarcelona,bsky.social
Reporter for Nature, mostly covering biology and medicine.
hledford.01 (Signal) and heidiledford (@proton.me)
I write the Nature Briefing, a daily email for Nature (@nature.com) about all the science, which I hope you will enjoy.
Senior Editor @Nature for cancer and cell cycle. Views my own
Deputy Editor at Nature, Cancer, Biomedicine, Genetics and Biotechnology. All views my own.
Chief Biological, Clinical and Social Sciences Editor of Nature
Any views expressed here are my own
Features editor, Nature. E: r⟦dot⟧vannoorden⟦at⟧nature⟦dot⟧com or richardvannoorden⟦at⟧protonmail⟦dot⟧com. Signal: richvn.01 . (Currently on parental leave, to April 2026).
Science journalist and correspondent for Nature (she/her). Reach me at alexwitze.01 (Signal), witzescience (@gmail.com), or awitze (@protonmail.com).
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
Cancer Physician Scientist
@caldaslab.bsky.social
@hebrewuniversity.bsky.social
@lautenbergc.bsky.social
Functional genomics.
Breast cancer ecosystems.
Cell state and cell fate.
Precision Cancer Medicine 2.0
#METABRIC
#DETECT
#TransNEO
#PDTXs
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians at Yale University and Smilow Cancer Hospital.
Assistant prof at Stanford. Interested in aneuploidy, mitotic kinases, cancer therapeutics, and drug development. Co-founder x2.
Physician-scientist at Children's Research Institute at UT Southwestern. Focused on #LiverCancer and organ regeneration.
The Rockefeller University is a world-renowned center for research and graduate education in the biomedical sciences, chemistry, bioinformatics and physics.
